Education
About Us
Working with TipRanks
Follow Us
Senti Biosciences, Inc. (SNTI)
:SNTI
SNTI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.52 - $16.94
Previous CloseN/A
Volume20.15K
Average Volume (3M)40.34K
Market Cap
$13.91M
Enterprise Value$34.57M
Total Cash (Recent Filing)$35.93M
Total Debt (Recent Filing)$37.67M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Mar 20, 2025EPS Estimate
-3.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.60
Shares Outstanding4,829,457
10 Day Avg. Volume55,686
30 Day Avg. Volume40,338
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)51.82
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap2.49
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-12.89
Enterprise Value/Ebitda-0.60
Forecast
1Y Price Target
$10.00Price Target Upside247.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
Senti Biosciences News
PremiumCompany Announcements
Senti Biosciences Appoints New CFO Jay Cross
PremiumCompany Announcements
Senti Biosciences Renews Consulting Agreement with Yvonne Li
---
Bulls Say, Bears Say
Bulls Say
Clinical Trial ResultsThe initial data from the phase I trial of SENTI-202 showed that 2 out of 3 patients achieved complete remission, which is seen as encouraging due to the link between MRD-negative CR and better outcomes in AML.
Financial StrategySenti additionally disclosed a $37.6 mm PIPE financing, which should support the company's continued execution on the '202 program.
Bears Say
Financial PositionThe company ended the quarter with a limited cash position of $10.5 million, which has decreased from the previous quarter.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNTI FAQ
What was Senti Biosciences, Inc.’s price range in the past 12 months?
Senti Biosciences, Inc. lowest stock price was $1.52 and its highest was $16.94 in the past 12 months.
What is Senti Biosciences, Inc.’s market cap?
Senti Biosciences, Inc.’s market cap is $13.91M.
When is Senti Biosciences, Inc.’s upcoming earnings report date?
Senti Biosciences, Inc.’s upcoming earnings report date is Mar 20, 2025 which is in 14 days.
How were Senti Biosciences, Inc.’s earnings last quarter?
Senti Biosciences, Inc. released its earnings results on Nov 14, 2024. The company reported -$6.31 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.31.
Is Senti Biosciences, Inc. overvalued?
According to Wall Street analysts Senti Biosciences, Inc.’s price is currently Undervalued.
Does Senti Biosciences, Inc. pay dividends?
Senti Biosciences, Inc. does not currently pay dividends.
What is Senti Biosciences, Inc.’s EPS estimate?
Senti Biosciences, Inc.’s EPS estimate is -3.13.
How many shares outstanding does Senti Biosciences, Inc. have?
Senti Biosciences, Inc. has 4,829,457 shares outstanding.
What happened to Senti Biosciences, Inc.’s price movement after its last earnings report?
Senti Biosciences, Inc. reported an EPS of -$6.31 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.725%.
Which hedge fund is a major shareholder of Senti Biosciences, Inc.?
Currently, no hedge funds are holding shares in SNTI
---
Company Description
Senti Biosciences, Inc.
Dynamics Special Purpose Corp is a blank check company.
---
SNTI Stock 12 Month Forecast
Average Price Target
$10.00
▲(247.22% Upside)
Technical Analysis
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Beam Therapeutics
―
Verve Therapeutics
―
Best Analysts Covering SNTI
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-55.30%
reiterated a buy rating 3 months ago
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -55.30% per trade.
---